HIV-1-associated neurocognitive disorder: epidemiology, pathogenesis, diagnosis, and treatment

C Eggers, G Arendt, K Hahn, IW Husstedt… - Journal of …, 2017 - Springer
The modern antiretroviral treatment of human immunodeficiency virus (HIV-1) infection has
considerably lowered the incidence of opportunistic infections. With the exception of the …

Controversies in HIV-associated neurocognitive disorders

S Nightingale, A Winston, S Letendre… - The Lancet …, 2014 - thelancet.com
Cross-sectional studies show that around half of individuals infected with HIV-1 have some
degree of cognitive impairment despite the use of antiretroviral drugs. However, prevalence …

GluT4: A central player in hippocampal memory and brain insulin resistance

EC McNay, J Pearson-Leary - Experimental neurology, 2020 - Elsevier
Insulin is now well-established as playing multiple roles within the brain, and specifically as
regulating hippocampal cognitive processes and metabolism. Impairments to insulin …

Efavirenz associated with cognitive disorders in otherwise asymptomatic HIV-infected patients

N Ciccarelli, M Fabbiani, S Di Giambenedetto, I Fanti… - Neurology, 2011 - AAN Enterprises
Background: Despite the availability of potent antiretroviral regimens (combination
antiretroviral therapy [cART]), HIV-associated neurocognitive disorders (HAND) are …

Current understanding of HIV-associated neurocognitive disorders pathogenesis

P Gannon, MZ Khan, DL Kolson - Current opinion in neurology, 2011 - journals.lww.com
Prevention and treatment of HAND requires strategies aimed at suppressing CNS HIV
replication and effects of systemic and CNS inflammation in aging and substance-abusing …

[PDF][PDF] BHIVA guidelines on antiretroviral treatment for adults living with HIV-1 2022

L Waters, A Winston, I Reeves, M Boffito… - HIV …, 2022 - discovery.ucl.ac.uk
The overall purpose of these guidelines is to provide guidance on best clinical practice for
antiretroviral therapy (ART) and management of adults living with human immunodeficiency …

Could antiretroviral neurotoxicity play a role in the pathogenesis of cognitive impairment in treated HIV disease?

J Underwood, KR Robertson, A Winston - Aids, 2015 - journals.lww.com
Whilst effective antiretroviral therapy is protective against the more severe forms of HIV-
associated brain disease, there remains a large burden of clinically symptomatic cognitive …

Cerebral vascular toxicity of antiretroviral therapy

L Bertrand, M Velichkovska, M Toborek - Journal of neuroimmune …, 2021 - Springer
HIV infection is associated with comorbidities that are likely to be driven not only by HIV
itself, but also by the toxicity of long-term use of antiretroviral therapy (ART). Indeed …

Neuronal toxicity of efavirenz: a systematic review

EH Decloedt, G Maartens - Expert opinion on drug safety, 2013 - Taylor & Francis
Introduction: Efavirenz commonly causes early neuropsychiatric side effects, but tolerance
develops in most patients. There is emerging evidence that efavirenz use may damage …

Dendritic spine injury induced by the 8-hydroxy metabolite of efavirenz

LB Tovar-y-Romo, NN Bumpus, D Pomerantz… - … of Pharmacology and …, 2012 - ASPET
Despite combination antiretroviral therapies (cARTs), a significant proportion of HIV-infected
patients develop HIV-associated neurocognitive disorders (HAND). Ongoing viral replication …